Steven A Shallcross insider trades
Open-market stock purchases and sales by Steven A Shallcross, CEO and CFO at Theriva Biologics, Inc, from SEC Form 4 filings since Apr 8, 2014.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 5, 2026 | TOVX Theriva Biologics, Inc | Bought (not open market) | — |
Companies traded
- TOVX Theriva Biologics, Inc: 7 buys, last Jan 5, 2026
- ELYS Elys Game Technology, Corp: other filings, last Feb 14, 2023
- SYN Synthetic Biologics, Inc: 2 buys, last Dec 23, 2021
- VEEE Twin Vee PowerCats, Co: other filings, last Jul 23, 2021
- NWGI Elys Game Technology, Corp: other filings, last Jan 22, 2021
- CMXI Cytomedix Inc: 2 buys, last Aug 26, 2014
Get free alerts when Steven A Shallcross files a new trade →